MNG:LSEM&G Plc Analysis
Data as of 2026-06-13 - not real-time
£321.60
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
M&G plc is trading at around £321.6, comfortably above its 20‑day SMA of £313 and 50‑day SMA of £303, indicating a short‑term bullish bias, but the RSI of 64 suggests the stock is edging into overbought territory. The MACD has turned bearish, and volume is on a decreasing trend, which together warn of a potential near‑term pull‑back. Fundamentally, the company posted a robust 37% revenue growth year‑over‑year and recorded net inflows of £0.6 bn in Q1, signaling renewed investor confidence. The forward PE of roughly 10× and a DCF‑derived fair value near £930 point to significant upside potential relative to the current price. However, the dividend payout ratio exceeds 160%, raising questions about the sustainability of the 6.37% yield. Overall, the mix of strong earnings momentum, attractive valuation gaps, and dividend concerns creates a nuanced outlook.
The asset‑management sector faces moderate regulatory scrutiny and is sensitive to market volatility, yet M&G’s diversified life‑insurance franchise provides a stabilising cash‑flow base. With a low beta (≈0.48) and moderate 30‑day volatility (~19%), the equity exhibits limited systematic risk, and its UK‑centric operations keep geographic and currency exposure low. Investors should weigh the short‑term technical softness against the longer‑term fundamentals and consider a cautious but optimistic positioning.
The asset‑management sector faces moderate regulatory scrutiny and is sensitive to market volatility, yet M&G’s diversified life‑insurance franchise provides a stabilising cash‑flow base. With a low beta (≈0.48) and moderate 30‑day volatility (~19%), the equity exhibits limited systematic risk, and its UK‑centric operations keep geographic and currency exposure low. Investors should weigh the short‑term technical softness against the longer‑term fundamentals and consider a cautious but optimistic positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal and decreasing volume
- RSI approaching overbought levels
- Price trading near recent resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value far above market price
- Strong revenue growth and Q1 net inflows
- Attractive forward PE around 10×
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Diversified life‑insurance and asset‑management franchise
- High dividend yield offset by payout sustainability concerns
- Low systematic risk (beta) and stable UK exposure
Key Metrics & Analysis
Financial Health
Revenue Growth37.00%
Profit Margin4.11%
P/E Ratio26.8
ROE9.64%
ROA0.85%
Debt/Equity216.81
P/B Ratio2.4
Op. Cash Flow£953.0M
Free Cash Flow£-3452875008
Industry P/E16.8
Technical Analysis
TrendBullish
RSI64.0
Support£302.60
Resistance£321.60
MA 20£313.36
MA 50£303.25
MA 200£285.91
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value£930.39
Target Price£308.84
Upside/Downside-3.97%
GradeUndervalued
TypeBlend
Dividend Yield6.37%
Risk Assessment
Beta0.48
Volatility19.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.